IL135400A0 - Aggregates of human insulin derivatives - Google Patents

Aggregates of human insulin derivatives

Info

Publication number
IL135400A0
IL135400A0 IL13540098A IL13540098A IL135400A0 IL 135400 A0 IL135400 A0 IL 135400A0 IL 13540098 A IL13540098 A IL 13540098A IL 13540098 A IL13540098 A IL 13540098A IL 135400 A0 IL135400 A0 IL 135400A0
Authority
IL
Israel
Prior art keywords
aggregates
derivatives
human insulin
soluble
insulin derivatives
Prior art date
Application number
IL13540098A
Other languages
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL135400A0 publication Critical patent/IL135400A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL13540098A 1997-10-24 1998-10-23 Aggregates of human insulin derivatives IL135400A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK121897 1997-10-24
US6417097P 1997-11-04 1997-11-04
PCT/DK1998/000461 WO1999021888A1 (en) 1997-10-24 1998-10-23 Aggregates of human insulin derivatives

Publications (1)

Publication Number Publication Date
IL135400A0 true IL135400A0 (en) 2001-05-20

Family

ID=26065414

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13540098A IL135400A0 (en) 1997-10-24 1998-10-23 Aggregates of human insulin derivatives
IL135400A IL135400A (en) 1997-10-24 2000-03-31 Accumulate humane insulin derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL135400A IL135400A (en) 1997-10-24 2000-03-31 Accumulate humane insulin derivatives

Country Status (20)

Country Link
EP (1) EP1025125B1 (ru)
JP (1) JP2003525846A (ru)
KR (1) KR100539193B1 (ru)
CN (1) CN1240718C (ru)
AT (1) ATE243711T1 (ru)
AU (1) AU757933B2 (ru)
BR (1) BR9813128A (ru)
CA (1) CA2308705A1 (ru)
DE (1) DE69815877T2 (ru)
DK (1) DK1025125T3 (ru)
ES (1) ES2202899T3 (ru)
HU (1) HUP0004096A3 (ru)
IL (2) IL135400A0 (ru)
NO (1) NO20002050L (ru)
PL (1) PL195845B1 (ru)
PT (1) PT1025125E (ru)
RU (1) RU2218349C2 (ru)
UA (1) UA69393C2 (ru)
WO (1) WO1999021888A1 (ru)
ZA (1) ZA989722B (ru)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7316999B2 (en) 2000-06-02 2008-01-08 Novo Nordisk A/S Glucose dependent release of insulin from glucose sensing insulin derivatives
MXPA03010649A (es) 2001-05-21 2005-10-05 Nektar Therapeutics Administracion pulmonar de insulina modificada quimicamente.
US7317000B2 (en) 2001-12-02 2008-01-08 Novo Nordisk A/S Glucose-dependent insulins
ES2472421T3 (es) * 2003-08-05 2014-07-01 Novo Nordisk A/S Nuevos derivados de insulina
EP2264065B1 (en) * 2003-08-05 2017-03-08 Novo Nordisk A/S Novel insulin derivatives
UA103758C2 (ru) * 2004-07-19 2013-11-25 Биокон Лимитед Конъюгаты олигомеров инсулина, их композиции и применение
EP1888104A2 (en) * 2005-05-26 2008-02-20 Novo Nordisk A/S Acylated insulin with high purity
PT1969004E (pt) 2005-12-28 2011-11-25 Novo Nordisk As Composições que compreendem uma insulina acilada e zinco e método para criar tais composições
ATE557037T1 (de) 2006-02-27 2012-05-15 Novo Nordisk As Insulin derivate
JP2009539778A (ja) * 2006-06-08 2009-11-19 ダイアベコア メディカル インコーポレイテッド インスリンオリゴマー誘導体
JP5550338B2 (ja) 2006-07-31 2014-07-16 ノボ・ノルデイスク・エー／エス ペグ化持続型インスリン
CN101541830A (zh) 2006-09-22 2009-09-23 诺沃-诺迪斯克有限公司 蛋白酶抗性的胰岛素类似物
ES2563038T3 (es) 2007-04-30 2016-03-10 Novo Nordisk A/S Método para secar una composición proteica, una composición proteica seca y una composición farmacéutica que comprende la proteína seca
ES2744384T3 (es) 2007-06-13 2020-02-24 Novo Nordisk As Formulación farmacéutica que comprende un derivado de insulina
ES2618073T3 (es) 2008-03-14 2017-06-20 Novo Nordisk A/S Análogos de insulina estabilizados frente a proteasas
EP2910571B1 (en) 2008-03-18 2016-10-05 Novo Nordisk A/S Protease stabilized, acylated insulin analogues
US9603904B2 (en) 2008-10-30 2017-03-28 Novo Nordisk A/S Treating diabetes melitus using insulin injections with less than daily injection frequency
BR112013010345A2 (pt) 2010-10-27 2017-07-25 Novo Nordisk As tratamento de diabetes melitus usando as injeções de insulina administradas com intervalos de variação da injeção
CN103191416A (zh) * 2012-01-05 2013-07-10 四川大学 一种猪胰岛素超分子聚集体及其制备方法
CA2870313A1 (en) 2012-04-11 2013-10-17 Novo Nordisk A/S Insulin formulations
EP2991672A1 (en) 2013-04-30 2016-03-09 Novo Nordisk A/S Novel administration regime
WO2015052088A1 (en) 2013-10-07 2015-04-16 Novo Nordisk A/S Novel derivative of an insulin analogue
AR099569A1 (es) 2014-02-28 2016-08-03 Novo Nordisk As Derivados de insulina y los usos médicos de estos
MX2019006463A (es) 2016-12-16 2019-08-14 Novo Nordisk As Composiciones farmaceuticas que contienen insulina.
KR102665710B1 (ko) 2017-08-24 2024-05-14 노보 노르디스크 에이/에스 Glp-1 조성물 및 그 용도
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin
US20230082544A1 (en) 2020-02-18 2023-03-16 Novo Nordisk A/S Pharmaceutical formulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559094A (en) * 1994-08-02 1996-09-24 Eli Lilly And Company AspB1 insulin analogs
US6451970B1 (en) * 1996-02-21 2002-09-17 Novo Nordisk A/S Peptide derivatives

Also Published As

Publication number Publication date
CN1281466A (zh) 2001-01-24
PL340032A1 (en) 2001-01-15
KR20010031247A (ko) 2001-04-16
NO20002050D0 (no) 2000-04-18
DE69815877T2 (de) 2004-05-19
EP1025125A1 (en) 2000-08-09
RU2218349C2 (ru) 2003-12-10
ZA989722B (en) 1999-04-26
CA2308705A1 (en) 1999-05-06
KR100539193B1 (ko) 2005-12-27
IL135400A (en) 2007-08-19
BR9813128A (pt) 2000-08-15
ATE243711T1 (de) 2003-07-15
HUP0004096A2 (hu) 2001-05-28
DK1025125T3 (da) 2003-10-06
DE69815877D1 (de) 2003-07-31
WO1999021888A1 (en) 1999-05-06
AU757933B2 (en) 2003-03-13
ES2202899T3 (es) 2004-04-01
JP2003525846A (ja) 2003-09-02
HUP0004096A3 (en) 2001-12-28
PT1025125E (pt) 2003-11-28
NO20002050L (no) 2000-06-23
AU9622198A (en) 1999-05-17
CN1240718C (zh) 2006-02-08
UA69393C2 (ru) 2004-09-15
PL195845B1 (pl) 2007-10-31
EP1025125B1 (en) 2003-06-25

Similar Documents

Publication Publication Date Title
ZA989722B (en) Aggregates of human insulin derivatives
CA2209060A1 (en) Water-soluble or water-swellable polymers
EP0886408A3 (en) Multicarrier modulation using guard intervals to reduce the effects of discontinuities
WO2002065684A8 (en) Data communication over a power line
HK1010196A1 (en) Novel 2,3-dioxo-1,2,3,4-tetrahdro-quinoyxalinyl derivatives.
AU4270596A (en) Human phosphodiesterase type ivc, and its production and use
AU633705B2 (en) Preparation of finely divided, water-soluble polymers
ZA968304B (en) Noval amino acid derivatives, their preparation and use.
AU3657100A (en) Use of water-soluble beta-(1,3) glucans as agents for producing therapeutic skintreatment agents
AU2894297A (en) 2,4-diaminopyrimidine derivatives
WO1997030092A3 (en) Hydrogels
EP0882447B8 (en) Soluble cosmetics
AU7624598A (en) 1,4-diazabicyclo (2.2.2) Oct-2-ylmethyl derivatives, their preparation and the rapeutic application
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
ZA971883B (en) 1,3,5-trisubstituted indazole derivatives.
ZA974084B (en) Novel α-glucuronidases, production hereof and their uses.
AU6180896A (en) Improved synthesis of 2,4,6,8,10,12-hexabenzyl-2,4,6,8,10,12-hexaazatetracyclo{5.5 .0.05,9.03,11}dodecane
CA2314716A1 (en) Modified polysaccharides exhibiting altered biological recognition
GB9726130D0 (en) 2,2'-BI-1H-pyrrole derivatives useful in the treatment of leukemia brought on by HTLV-I
AU776463C (en) Decorative cosmetic preparations
ZA967537B (en) Novel carboxylic acid derivatives, their preparation and use.
AU5589499A (en) Water-soluble, hydrolytic-stable amphoteric monomer and polymers therefrom
AU4605399A (en) Novel 3,4-diaminophenol derivatives and their use
EP0758676A3 (de) Filmbildende, wässrige Metallphosphat-Amin-Komplex-Lösungen und deren Verwendung
AU4723897A (en) 1,4-benzoquinone derivatives

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees